DNLI
Denali TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
DNLI vs peer average
53/100
DNLI vs. peer average (C vs. C)
Grade spread
B 3 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BEAM is the first available peer comparator.
Similar-sized biopharma where valuation is driven by platform validation, clinical readouts, and financing/runway confidence rather than near-term steady-state earnings.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DNLI
Denali Therapeutics
BEAM
Beam Therapeutics
Grade
C
C
Momentum
79
44
Value
41
41
Sentiment
46
68
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs BEAM
DNLI / BEAM
Grade Position
In line
DNLI vs. peer average (C vs. C)
53/100
Momentum
79
DNLIValue
41
DNLISentiment
46
BEAMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DNLI
BEAM is the first peer returned for this comparison set.